Cited by 2,969Hematopoietic Stem Cell TransplantationInflammatory Biomarkers in Disease PrognosisRenal Transplantation Outcomes and Treatments

The DOI matches its Crossref record; 61 of the 62 references it cites were found in a registry or an index.

Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT

Open access

Sorror, Mohamed L., Maris, Michael B., Storb, Rainer, Baron, Frederic, Sandmaier, Brenda M., Maloney, David G., Storer, Barry·2005·Blood

DOI 10.1182/blood-2005-05-2004PMC PMC1895304

Open this paper in CoChat — free account Open PDF

Abstract

We previously reported that the Charlson Comorbidity Index (CCI) was useful for predicting outcomes in patients undergoing allogeneic hematopoietic cell transplantation (HCT). However, the sample size of patients with scores of 1 or more, captured by the CCI, did not exceed 35%. Further, some comorbidities were rarely found among patients who underwent HCT. Therefore, the current study was designed to (1) better define previously identified comorbidities using pretransplant laboratory data, (2) investigate additional HCT-related comorbidities, and (3) establish comorbidity scores that were suited for HCT. Data were collected from 1055 patients, and then randomly divided into training and validation sets. Weights were assigned to individual comorbidities according to their prognostic significance in Cox proportional hazard models. The new index was then validated. The new index proved to be more sensitive than the CCI since it captured 62% of patients with scores more than 0 compared with 12%, respectively. Further, the new index showed better survival prediction than the CCI (likelihood ratio of 23.7 versus 7.1 and c statistics of 0.661 versus 0.561, respectively, P < .001). In conclusion, the new simple index provided valid and reliable scoring of pretransplant comorbidities that predicted nonrelapse mortality and survival. This index will be useful for clinical trials and patient counseling before HCT. (Blood. 2005;106: 2912-2919)

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1182/blood-2005-05-2004

Cites

61 of 61 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation
Charlson, M. E., Pompei, P., Ales, K. L., & MacKenzie, C. R. (1987) · Journal of Chronic Diseases · doi:10.1016/0021-9681(87)90171-8 · Cited by 49,742
Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases
DEYO, R. (1992) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(92)90133-8 · Cited by 10,452
The Statistical Analysis of Failure Time Data.
Aitkin, M. A., Kalbfleisch, J. D., & Prentice, R. L. (1981) · Biometrics · doi:10.2307/2530581 · Cited by 9,875
Validation of a combined comorbidity index
Charlson, M., Szatrowski, T. P., Peterson, J., & Gold, J. (1994) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(94)90129-5 · Cited by 6,587
International scoring system for evaluating prognosis in myelodysplastic syndromes
Greenberg, P., Cox, C., LeBeau, M. M., Fenaux, P., Morel, P., Sanz, G., Sanz, M., Vallespi, T., Hamblin, T., Oscier, D., et al. (1997) · Blood · doi:10.1182/blood.v89.6.2079 · Cited by 4,427
Regression modelling strategies for improved prognostic prediction
Harrell, F. E., Lee, K. L., Califf, R. M., Pryor, D. B., & Rosati, R. A. (1984) · Statistics in Medicine · doi:10.1002/sim.4780030207 · Cited by 1,804
Presentation adapting a clinical comorbidity index for use with ICD-9-CM administrative data: Differing perspectives
Romano, P. S., Roos, L. L., & Jollis, J. G. (1993) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(93)90103-8 · Cited by 1,717
The pre-therapeutic classification of co-morbidity in chronic disease
Feinstein, A. R. (1970) · Journal of Chronic Diseases · doi:10.1016/0021-9681(70)90054-8 · Cited by 1,544
Methotrexate and Cyclosporine Compared with Cyclosporine Alone for Prophylaxis of Acute Graft versus Host Disease after Marrow Transplantation for Leukemia
Storb, R. F., Deeg, H. J., Whitehead, J., Appelbaum, F. R., Beatty, P. G., Bensinger, W., Buckner, C. D., Clift, R. A., Doney, K., Farewell, V. T., et al. (1986) · New England Journal of Medicine · doi:10.1056/nejm198603203141201 · Cited by 1,411
Self-citation
Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects
McSweeney, P. A., Niederwieser, D. W., Shizuru, J. A., Sandmaier, B. M., Molina, A. J., Maloney, D. G., Chauncey, T. R., Gooley, T. A., Hegenbart, U., Nash, R. A., et al. (2001) · Blood · doi:10.1182/blood.v97.11.3390 · Cited by 1,386
Self-citation

Show all 62 references

Research works printed but not linked: 1

Lubke T, Monig SP, Schneider PM, Holscher AH, Bollschweiler E. Does Charlson-comorbidity index correlate with short-term outcome in patients with gastric cancer? [German]. Zentralblatt für Chirurgie.2003;128: 970-976.

Sorted by citations

Items 701–800 of 1,002

Elderly Acute Myeloid Leukemia: Assessing Risk
Klepin, H. D. (2015) · Current Hematologic Malignancy Reports · doi:10.1007/s11899-015-0257-2 · Cited by 31
Second allogeneic hematopoietic cell transplantation enables long-term disease-free survival in relapsed acute leukemia
Schneidawind, C., Hagmaier, V., Faul, C., Kanz, L., Bethge, W. A., & Schneidawind, D. (2018) · Annals of Hematology · doi:10.1007/s00277-018-3454-y · Cited by 31
Management of Newly Diagnosed Elderly Multiple Myeloma Patients
Antoine-Pepeljugoski, C., & Braunstein, M. J. (2019) · Current Oncology Reports · doi:10.1007/s11912-019-0804-4 · Cited by 33
Haploidentical transplantation using posttransplant cyclophosphamide as GVHD prophylaxis in patients over age 70
Imus, P. H., Tsai, H., Luznik, L., Fuchs, E. J., Huff, C. A., Gladstone, D. E., Lowery, P., Ambinder, R. F., Borrello, I., Swinnen, L. J., et al. (2019) · Blood Advances · doi:10.1182/bloodadvances.2019000155 · Cited by 31
The role of allogeneic stem-cell transplant in myelofibrosis in the era of JAK inhibitors: a case-based review
Tiribelli, M., Palandri, F., Sant’Antonio, E., Breccia, M., & Bonifacio, M. (2019) · Bone Marrow Transplantation · doi:10.1038/s41409-019-0683-1 · Cited by 31
Prognostic factors and outcome of adult allogeneic hematopoietic stem cell transplantation patients admitted to intensive care unit during transplant hospitalization
Michel, C. S., Teschner, D., Schmidtmann, I. M., Theobald, M., Hauptrock, B., Wagner-Drouet, E., & Radsak, M. P. (2019) · Scientific Reports · doi:10.1038/s41598-019-56322-0 · Cited by 31
A reproducible and safe at-home allogeneic haematopoietic cell transplant program: first experience in Central and Southern Europe
Gutiérrez, G., Rovira, M., Arab, N., Gallego, C., Sánchez, J., Álvarez, M. Á., Ayora, P., Domènech, A., Borràs, N., Rodríguez‐Lobato, L. G., et al. (2020) · Bone Marrow Transplantation · doi:10.1038/s41409-019-0768-x · Cited by 31
Allogeneic transplantation for Ph+ acute lymphoblastic leukemia with posttransplantation cyclophosphamide
Webster, J. A., Luznik, L., Tsai, H., Imus, P. H., Dezern, A. E., Pratz, K. W., Levis, M. J., Gojo, I., Showel, M. M., Prince, G. T., et al. (2020) · Blood Advances · doi:10.1182/bloodadvances.2020002945 · Cited by 31
Sharing and caring: The impact of social support on quality of life and health outcomes in hematopoietic stem cell transplantation
Amonoo, H. L., Johnson, P. C., Dhawale, T. M., Traeger, L. N., Rice, J., Lavoie, M. W., Ufere, N. N., Longley, R. M., Harnedy, L. E., Clay, M. A., et al. (2021) · Cancer · doi:10.1002/cncr.33455 · Cited by 33
Steroid-dependent acute GVHD after allogeneic hematopoietic cell transplantation: risk factors and clinical outcomes
Jurdi, N. E., Rayes, A., MacMillan, M. L., Holtan, S. G., DeFor, T. E., Witte, J., Arora, M., Young, J. H., & Weisdorf, D. J. (2021) · Blood Advances · doi:10.1182/bloodadvances.2020003937 · Cited by 31
Allogeneic hematopoietic cell transplantation in older myelofibrosis patients: A study of the chronic malignancies working party of EBMT and the Spanish Myelofibrosis Registry
Hernández‐Boluda, J. C., Pereira, A., Kröger, N. M., Cornelissen, J. J., Finke, J., Beelen, D. W., de Witte, M. A., Wilson, K. M. O., Platzbecker, U., Sengeloev, H., et al. (2021) · American Journal of Hematology · doi:10.1002/ajh.26279 · Cited by 31
Impact of hematopoietic cell transplant frailty scale on transplant outcome in adults
Salas, M. Q., Atenafu, E. G., Pašić, I., Al‐Shaibani, E., Bascom, O., Wilson, L., Chen, C. C. L., Law, A., Lam, W., Novitzky‐Basso, I., et al. (2022) · Bone Marrow Transplantation · doi:10.1038/s41409-022-01892-3 · Cited by 29
Prognostic significance of pre-transplant quality of life in allogeneic hematopoietic cell transplantation recipients
Hamilton, B. K., Law, A., Rybicki, L. A., Abounader, D., Dabney, J., Dean, R. M., Duong, H. K., Gerds, A. T., Hanna, R., Hill, B. T., et al. (2015) · Bone Marrow Transplantation · doi:10.1038/bmt.2015.122 · Cited by 31
Allogeneic Hematopoietic Cell Transplantation following Minimal Intensity Conditioning: Predicting Acute Graft-versus-Host Disease and Graft-versus-Tumor Effects
Storb, R. F., Gyurkocza, B., Storer, B. E., Maloney, D. G., Sorror, M. L., Mielcarek, M. B., Martin, P. J., & Sandmaier, B. M. (2013) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2013.02.006 · Cited by 31
Self-citation
Viral encephalitis after haplo‐identical hematopoietic stem cell transplantation: Causative viral spectrum, characteristics, and risk factors
Zhang, X., Zhang, J., Han, W., Chen, H., Chen, Y., Wang, F., Wang, J., Zhang, Y., Mo, X., Yao, C., et al. (2017) · European Journal Of Haematology · doi:10.1111/ejh.12855 · Cited by 31
Predictive Role of Circulating Immune Cell Subtypes Early after Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Leukemia
Kim, T., Park, S., Lim, J.-Y., Min, G. J., Park, S., Jeon, Y., Yahng, S., Shin, S.-H., Lee, S., Yoon, J., et al. (2018) · International Journal of Stem Cells · doi:10.15283/ijsc18094 · Cited by 31
Optimization of Transplant Regimens for Patients with Myelodysplastic Syndrome (MDS)
Deeg, H. J. (2005) · Hematology · doi:10.1182/asheducation-2005.1.167 · Cited by 31
Retinal dystrophy in the pigmented rat.
Herron, W. L., Riegel, B. W., Brennan, E., & Rubin, M. L. (1974) · PubMed · Cited by 31
Orca-T vs allogeneic hematopoietic stem cell transplantation (Precision-T): a multicenter, randomized phase 3 trial
Meyer, E. H., Salhotra, A., Gandhi, A. P., Pantin, J. M., Patel, S. S., Hoeg, R. T., Gomez-Arteaga, A., Faramand, R. G., Tamari, R., Waller, E. K., et al. (2025) · Blood · doi:10.1182/blood.2025031313 · Cited by 30
A scoring system to predict the risk of death during induction with anthracycline plus cytarabine‐based chemotherapy in patients with de novo acute myeloid leukemia
Valcárcel, D., Montesinos, P., Sánchez‐Ortega, I., Brunet, S., Esteve, J., Martínez‐Cuadrón, D., Ribera, J., Tormo, M., Bueno, J., Duarte, R. F., et al. (2011) · Cancer · doi:10.1002/cncr.26273 · Cited by 30
Intermediate intensity conditioning regimen containing FLAMSA, treosulfan, cyclophosphamide, and ATG for allogeneic stem cell transplantation in elderly patients with relapsed or high-risk acute myeloid leukemia
Chemnitz, J. M., von Lilienfeld‐Toal, M., Holtick, U., Theurich, S., Shimabukuro‐Vornhagen, A., Krause, A., Brossart, P., Hallek, M. J., & Scheid, C. (2011) · Annals of Hematology · doi:10.1007/s00277-011-1253-9 · Cited by 30
Treatment option of bendamustine in combination with rituximab in elderly and frail patients with aggressive B-non-Hodgkin lymphoma: rational, efficacy, and tolerance
Horn, J., Kleber, M., Hieke, S., Schmitt-Graeff, A. H., Wäsch, R., & Engelhardt, M. M. (2012) · Annals of Hematology · doi:10.1007/s00277-012-1503-5 · Cited by 30
Multicenter Experience Using Total Lymphoid Irradiation and Antithymocyte Globulin as Conditioning for Allografting in Hematological Malignancies
Messina, G., Giaccone, L., Festuccia, M. B., Irrera, G., Scortechini, I., Sorasio, R., Gigli, F., Passera, R., Cavattoni, I., Filippi, A. R., et al. (2012) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2012.03.012 · Cited by 30
Trends in survival of multiple myeloma: A thirty-year population-based study in a single institution
Ríos, R., Sánchez, M., Puerta, J. M., Sáinz, J., Chang, D. Y. L., Rodríguez, T., López, P., Pablos, J. M. D., Navarro, P., Silva, J. L. G. D. V., et al. (2015) · Cancer Epidemiology · doi:10.1016/j.canep.2015.08.002 · Cited by 31
Allogeneic stem cell transplantation in acute lymphoblastic leukemia patients older than 60 years: a survey from the acute leukemia working party of EBMT
Roth-Guépin, G., Canaani, J., Ruggeri, A., Labopin, M., Finke, J., Cornelissen, J. J., Delage, J., Stuhler, G., Rovira, M., Potter, M. N., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.22934 · Cited by 30
Autologous Stem Cell Transplantation in Elderly Lymphoma Patients in Their 70s: Outcomes and Analysis
Sun, L., Li, S., El-Jawahri, A. R., Armand, P. A., Dey, B. R., Fisher, D. C., Jacobsen, E. D., Jacobson, C. A., LaCasce, A. S., McAfee, S. L., et al. (2017) · The Oncologist · doi:10.1634/theoncologist.2017-0499 · Cited by 30
Impact of severe acute kidney injury and chronic kidney disease on allogeneic hematopoietic cell transplant recipients: a retrospective single center analysis
Gutiérrez, G., Villarreal, J. Z., Garrote, M., Rovira, M., Blasco, M., Suárez‐Lledó, M., Rodríguez‐Lobato, L. G., Charry, P. A., Rosiñol, L., Marı́n, P., et al. (2020) · Bone Marrow Transplantation · doi:10.1038/s41409-020-0843-3 · Cited by 30
Post-transplant Cyclophosphamide Versus Thymoglobulin in HLA-Mismatched Unrelated Donor Transplant for Acute Myelogenous Leukemia and Myelodysplastic Syndrome
Modi, D., Kondrat, K., Kim, S., Deol, A., Ayash, L. J., Ratanatharathorn, V., & Uberti, J. P. (2021) · Transplantation and Cellular Therapy · doi:10.1016/j.jtct.2021.06.018 · Cited by 30
Noninfectious Pulmonary Toxicity after Allogeneic Hematopoietic Cell Transplantation
Patel, S. S., Ahn, K. W., Khanal, M., Bupp, C., Allbee‐Johnson, M., Majhail, N. S., Hamilton, B. K., Rotz, S. J., Hashem, H., Beitinjaneh, A., et al. (2022) · Transplantation and Cellular Therapy · doi:10.1016/j.jtct.2022.03.015 · Cited by 30
Self-citation
Hematopoietic Stem Cell Transplantation in Patients with Systolic Dysfunction: Can It Be Done?
Hurley, P., Konety, S., Cao, Q., Weisdorf, D. J., & Blaes, A. H. (2014) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2014.10.011 · Cited by 30
Carbon Monoxide Diffusion Capacity: How Low Can You Go for Hematopoietic Cell Transplantation Eligibility?
Chien, J. W., & Sullivan, K. M. (2009) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2008.12.509 · Cited by 30
High Level of Serum Soluble Interleukin-2 Receptor at Transplantation Predicts Poor Outcome of Allogeneic Stem Cell Transplantation for Adult T Cell Leukemia
Shigematsu, A., Kobayashi, N., Yasui, H., Shindo, M., Kakinoki, Y., Koda, K., Iyama, S., Kuroda, H., Tsutsumi, Y., Imamura, M., et al. (2014) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2014.02.014 · Cited by 30
Impacts of Pretransplant Comorbidities on Allogeneic Hematopoietic Cell Transplantation (HCT) Outcomes
Sorror, M. L. (2009) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2008.12.498 · Cited by 30
Self-citation
Early CMV-replication after allogeneic stem cell transplantation is associated with a reduced relapse risk in lymphoma
Koldehoff, M., Ross, S. R., Dührsen, U., Beelen, D. W., & Elmaagacli, A. H. (2016) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2016.1217524 · Cited by 30
Age does not adversely influence outcomes among patients older than 60 years who undergo allogeneic hematopoietic stem cell transplant for AML and myelodysplastic syndrome
Modi, D., Deol, A., Kim, S., Ayash, L. J., Alavi, A., Ventimiglia, M., Bhutani, D., Ratanatharathorn, V., & Uberti, J. P. (2017) · Bone Marrow Transplantation · doi:10.1038/bmt.2017.182 · Cited by 30
Evaluation of compliance with the Tokyo Guidelines for the management of acute cholangitis based on the Japanese administrative database associated with the Diagnosis Procedure Combination system
Murata, A., Matsuda, S., Kuwabara, K., Fujino, Y., Kubo, T., Fujimori, K., & Horiguchi, H. (2010) · Journal of Hepato-Biliary-Pancreatic Sciences · doi:10.1007/s00534-010-0302-4 · Cited by 29
Risk assessment before allogeneic hematopoietic cell transplantation for older adults with acute myeloid leukemia
Sorror, M. L., & Appelbaum, F. R. (2013) · Expert Review of Hematology · doi:10.1586/17474086.2013.827418 · Cited by 30
Self-citation
Current Management and Recent Advances in the Treatment of Chronic Myelomonocytic Leukemia
Hunter, A. M., Zhang, L., & Padron, E. (2018) · Current Treatment Options in Oncology · doi:10.1007/s11864-018-0581-6 · Cited by 29
Relative impact of residual cytogenetic abnormalities and flow cytometric measurable residual disease on outcome after allogeneic hematopoietic cell transplantation in adult acute myeloid leukemia
Orvain, C., Wilson, J. A., Fang, M., Sandmaier, B. M., Arboli, E. R., Wood, B. L., Othus, M. K. D., Appelbaum, F. R., & Walter, R. B. (2022) · Haematologica · doi:10.3324/haematol.2022.281585 · Cited by 29
Self-citation
Comparison of transplant outcomes between haploidentical transplantation and single cord blood transplantation in non‐remission acute myeloid leukaemia: A nationwide retrospective study
Matsuda, K., Konuma, T., Fuse, K., Masuko, M., Kawamura, K., Hirayama, M., Uchida, N., Ikegame, K., Wake, A., Eto, T., et al. (2022) · British Journal of Haematology · doi:10.1111/bjh.18530 · Cited by 29
Umbilical Cord Blood as an Alternative Source of Reduced-Intensity Hematopoietic Stem Cell Transplantation for Chronic Epstein-Barr Virus–Associated T or Natural Killer Cell Lymphoproliferative Diseases
Sawada, A., Inoue, M., Koyama, M., Kondo, O., Yamada, K., Shimizu, M., Isaka, K., Kimoto, T., Kikuchi, H., Tokimasa, S., et al. (2013) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2013.10.026 · Cited by 29
The outcome of haemopoietic stem cell transplantation in the treatment of lymphoplasmacytic lymphoma in the UK: a British Society Bone Marrow Transplantation study
Gilleece, M. H., Pearce, R., Linch, D. C., Wilson, M. C., Towlson, K. E., Mackinnon, S., Potter, M. N., Kazmi, M. A., Gribben, J. G., & Marks, D. I. (2008) · Hematology · doi:10.1179/102453308x315915 · Cited by 29
Pretransplant Metabolic Distress Predicts Relapse of Acute Myeloid Leukemia After Allogeneic Stem Cell Transplantation
Dietrich, S., Radujkovic, A., Stölzel, F., Falk, C. S., Benner, A., Schaich, M. A., Bornhäuser, M., Ehninger, G., Krämer, A., Hegenbart, U., et al. (2014) · Transplantation · doi:10.1097/tp.0000000000000471 · Cited by 29
Evaluation of allogeneic transplantation in first or later minimal residual disease – negative remission following adult-inspired therapy for acute lymphoblastic leukemia
Cassaday, R. D., Potts, D. A., Stevenson, P. A., Bar, M., Georges, G. E., Shustov, A. R., Sorror, M. L., Wood, B. L., Delaney, C., Doney, K., et al. (2016) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2016.1160080 · Cited by 29
Self-citation
Graft-versus-Host Disease–Free, Relapse-Free Survival after Allogeneic Stem Cell Transplantation for Myelodysplastic Syndrome
Park, S., Jeon, Y., Min, G. J., Park, S., Yahng, S., Yoon, J., Shin, S., Lee, S., Cho, B., Eom, K., et al. (2018) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2018.08.004 · Cited by 29
Autologous transplantation in elderly patients with multiple myeloma: are we asking the right questions?
Klepin, H. D., & Hurd, D. D. (2006) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1705486 · Cited by 29
Cardiovascular Risk Stratification of Patients Undergoing Hematopoietic Stem Cell Transplantation: The CARE‐BMT Risk Score
Vasbinder, A. L., Catalan, T., Anderson, E. L., Chu, C., Kotzin, M., Murphy, D. A., Cheplowitz, H., Diaz, K. M., Bitterman, B., Pizzo, I., et al. (2023) · Journal of the American Heart Association · doi:10.1161/jaha.123.033599 · Cited by 28
Clinical-genomic profiling of MDS to inform allo-HCT: recommendations from an international panel on behalf of the EBMT
Gurnari, C., Robin, M., Adès, L., Aljurf, M. D., Almeida, A. M., Duarte, F. B., Bernard, E., Cutler, C. S., Porta, M. G. D., de Witte, T. M., et al. (2025) · Blood · doi:10.1182/blood.2024025131 · Cited by 29
Hypomethylating agent induction therapy followed by hematopoietic cell transplantation is feasible in patients with myelodysplastic syndromes.
Cogle, C. R., Imanirad, I., Wiggins, L. E., Hsu, J. W., Brown, R. A., Scornik, J. C., & Wingard, J. R. (2010) · PubMed · Cited by 28
Incidence of invasive fungal disease after unmanipulated haploidentical stem cell transplantation was significantly higher than that after HLA-matched sibling transplantation
Sun, Y., Xu, L., Liu, D.-H., Zhang, X., Han, W., Wang, Y., Chen, H., Chen, Y., Wang, F., Wang, J., et al. (2012) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12120 · Cited by 28
Hematopoietic Cell Transplantation Comorbidity Index Predicts Outcomes in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndromes Receiving CD34+ Selected Grafts for Allogeneic Hematopoietic Cell Transplantation
Barba, P., Ratan, R., Cho, C., Ceberio, I., Hilden, P. D., Devlin, S. M., Maloy, M., Barker, J. N., Castro-Malaspina, H. R., Jakubowski, A. A., et al. (2016) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2016.10.017 · Cited by 28
Cost-effectiveness analysis of haploidentical vs matched unrelated allogeneic hematopoietic stem cells transplantation in patients older than 55 years
Debals-Gonthier, M., Siani, C., Faucher, C., Touzani, R., Lemarié, C., Chabannon, C., Fürst, S., Devillier, R., Harbi, S., Castagna, L., et al. (2018) · Bone Marrow Transplantation · doi:10.1038/s41409-018-0133-5 · Cited by 28
Clinical impact of the CONUT score and mogamulizumab in adult T cell leukemia/lymphoma
Ureshino, H., Kusaba, K., Kidoguchi, K., Sano, H., Nishioka, A., Itamura, H., Yoshimura, M., Yokoo, M., Shindo, T., Kubota, Y., et al. (2018) · Annals of Hematology · doi:10.1007/s00277-018-3502-7 · Cited by 28
Eligibility Criteria for Patients Undergoing Allogeneic Hematopoietic Cell Transplantation
Kanate, A. S., Perales, M., & Hamadani, M. (2020) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2020.7559 · Cited by 28
Conditioning regimen intensity and low-dose azacitidine maintenance after allogeneic hematopoietic cell transplantation for acute myeloid leukemia
Ali, N. J., Tomlinson, B. K., Metheny, L. L., Goldstein, S. C., Fu, P., Cao, S., Caimi, P. F., Patel, R. D., Varela, J. C., Andrade, L., et al. (2020) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2020.1789630 · Cited by 28
Predicting Survival after Allogeneic Hematopoietic Cell Transplantation in Myelofibrosis: Performance of the Myelofibrosis Transplant Scoring System (MTSS) and Development of a New Prognostic Model
Hernández‐Boluda, J. C., Pereira, A., Álvarez‐Larrán, A., Martín, A.-Á., Benzaquen, A. O., Aguirre, L., Mora, E., González-Sierra, P. A., Mora, J., Dorado, N., et al. (2020) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2020.07.022 · Cited by 28
Hematopoietic cell transplantation comorbidity index (HCT-CI) is predictive of adverse events and overall survival in older allogeneic transplant recipients
Keller, J. W., Andreadis, C. B., Damon, L. E., Kaplan, L. D., Martin, T. G., Wolf, J. L., Ai, W. Z., Venstrom, J. M., Smith, C. C., Gaensler, K. M. L., et al. (2014) · Journal of Geriatric Oncology · doi:10.1016/j.jgo.2014.04.003 · Cited by 28
New insights in the management of elderly patients with acute myeloid leukemia
Dombret, H., Raffoux, E., & Gardin, C. (2009) · Current Opinion in Oncology · doi:10.1097/cco.0b013e3283313e10 · Cited by 28
Hematopoietic Stem Cell Transplantation in Patients With Chronic Kidney Disease
Heher, E. C., & Spitzer, T. R. (2010) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2010.09.008 · Cited by 28
Similar Risks for Chronic Kidney Disease in Long-Term Survivors of Myeloablative and Reduced-Intensity Allogeneic Hematopoietic Cell Transplantation
Al-Hazzouri, A., Cao, Q., Burns, L. J., Weisdorf, D. J., & Majhail, N. S. (2008) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2008.03.008 · Cited by 29
Discharge Needs of Allogeneic Transplantation Recipients
Cooke, L., GRANT, M. M., & Gemmill, R. (2012) · Clinical journal of oncology nursing · doi:10.1188/12.cjon.e142-e149 · Cited by 28
Comorbidity as a risk factor for overall survival and decision criteria for intensity of chemotherapy in elderly patients with acute myeloid leukemia
Đjunić, I., Virijević, M., Novković, A., Djurasinovic, V., Čolović, N., Vidović, A., Suvajdžić, N., & Tomin, D. (2011) · Medical Oncology · doi:10.1007/s12032-011-9853-8 · Cited by 28
Severe Hypoalbuminemia at Day 90 Predicts Worse Nonrelapse Mortality and Overall Survival after Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myelogenous Leukemia and Myelodysplastic Syndrome
Kharfan‐Dabaja, M. A., Chávez, J. C., Yu, D., Zhu, W., Fernandez-Vertiz, E. I., Perkins, J. B., Shapiro, J., Bookout, R., Perez, L. E., Fernandez, H. F., et al. (2010) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2010.07.011 · Cited by 28
G‐CSF administration prior to donor lymphocyte apheresis promotes anti‐leukaemic effects in allogeneic HCT patients
Schneidawind, C., Jahnke, S., Schober‐Melms, I., Schumm, M., Handgretinger, R., Faul, C., Kanz, L., Bethge, W. A., & Schneidawind, D. (2019) · British Journal of Haematology · doi:10.1111/bjh.15881 · Cited by 28
Geriatric assessment for the practicing clinician: The why, what, and how
Magnuson, A. M., Loh, K. P., Stauffer, F., Dale, W., Gilmore, N. J., Kadambi, S. G., Klepin, H. D., Kyi, K., Lowenstein, L. M., Phillips, T., et al. (2024) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21864 · Cited by 28
Comorbidity and geriatric assessment for older patients with hematologic malignancies: A review of the evidence
Extermann, M., & Wedding, U. (2011) · Journal of Geriatric Oncology · doi:10.1016/j.jgo.2011.11.004 · Cited by 27
Innovative strategies minimize engraftment syndrome in multiple myeloma patients with novel induction therapy following autologous hematopoietic stem cell transplantation
Gutiérrez, G., Rovira, M., Magnano, L., Rosiñol, L., Bataller, Á., Suárez‐Lledó, M., Cibeira, M. T., de Larrea, C. F., Garrote, M., Jorge, S. C., et al. (2018) · Bone Marrow Transplantation · doi:10.1038/s41409-018-0189-2 · Cited by 27
Outcomes of Haploidentical Transplantation in Patients with Relapsed Multiple Myeloma: An EBMT/CIBMTR Report
Sahebi, F., Garderet, L., Kanate, A. S., Eikema, D.-J., Knelange, N. S., Alvelo, O. F. D., Koç, Y., Blaise, D., Bashir, Q., Moraleda, J. M., et al. (2018) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2018.09.018 · Cited by 29
Direct HLA Genetic Comparisons Identify Highly Matched Unrelated Donor-Recipient Pairs with Improved Transplantation Outcome
Vazirabad, I., Chhabra, S., Nytes, J., Mehra, V., Narra, R. K., Szabó, A., Jerkins, J. H., Dhakal, B., Hari, P., & Anderson, M. W. (2018) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2018.12.006 · Cited by 27
High-grade B-cell lymphoma: how to diagnose and treat
Novo, M., Castellino, A., Nicolosi, M., Santambrogio, E., Vassallo, F., Chiappella, A., & Vitolo, U. (2019) · Expert Review of Hematology · doi:10.1080/17474086.2019.1624157 · Cited by 26
Predicting non-relapse mortality following allogeneic hematopoietic cell transplantation during first remission of acute myeloid leukemia
Yanada, M., Konuma, T., Mizuno, S., Saburi, M., Shinohara, A., Tanaka, M., Marumo, A., Sawa, M., Uchida, N., Ozawa, Y., et al. (2020) · Bone Marrow Transplantation · doi:10.1038/s41409-020-01032-9 · Cited by 27
Prognostic Biomarkers for Thrombotic Microangiopathy after Acute Graft-versus-Host Disease: A Nested Case-Control Study
Li, A., Bhatraju, P. K., Chen, J., Chung, D. W., Hilton, T., Houck, K., Pao, E. C., Weiss, N. S., Lee, S. J., Davis, C., et al. (2020) · Transplantation and Cellular Therapy · doi:10.1016/j.jtct.2020.12.010 · Cited by 27
Impact of Pretransplantation Renal Dysfunction on Outcomes after Allogeneic Hematopoietic Cell Transplantation
Farhadfar, N., Dias, A., Wang, T., Fretham, C., Chhabra, S., Murthy, H. S., Broglie, L. A., D’Souza, A., Gadalla, S. M., Gale, R. P., et al. (2021) · Transplantation and Cellular Therapy · doi:10.1016/j.jtct.2021.02.030 · Cited by 28
Self-citation
An adapted European LeukemiaNet genetic risk stratification for acute myeloid leukemia patients undergoing allogeneic hematopoietic cell transplant. A CIBMTR analysis
Jiménez, A., Lima, M. J. G. D., Komanduri, K. V., Wang, T. P., Zhang, M., Chen, K., Abdel‐Azim, H., Abid, M. B., Aljurf, M. D., Alkhateeb, H. B., et al. (2021) · Bone Marrow Transplantation · doi:10.1038/s41409-021-01450-3 · Cited by 27
Self-citation
Association of pre-existing comorbidities with outcome of allogeneic hematopoietic cell transplantation. A retrospective analysis from the EBMT
Penack, O., Peczynski, C., Mohty, M., Yakoub‐Agha, I., de la Cámara, R., Glaß, B., Duarte, R. F., Kröger, N. M., Schoemans, H. M., Koenecke, C., et al. (2021) · Bone Marrow Transplantation · doi:10.1038/s41409-021-01502-8 · Cited by 27
Establishment of a predictive model for GVHD-free, relapse-free survival after allogeneic HSCT using ensemble learning
Iwasaki, M., Kanda, J., Arai, Y., Kondo, T., Ishikawa, T., Ueda, Y., Imada, K., Akasaka, T., Yonezawa, A., Yago, K., et al. (2021) · Blood Advances · doi:10.1182/bloodadvances.2021005800 · Cited by 27
Impact of Post-Transplantation Cyclophosphamide on Transfusion Requirements in HLA-Matched Sibling Peripheral Blood Stem Cell Transplantation
Marco-Ayala, J., Sanz, J., Gómez‐Seguí, I., Balaguer‐Roselló, A., Montoro, J., Guerreiro, M., Chorão, P., Facal, A., Villalba, M., Sanz, M. Á., et al. (2023) · Transplantation and Cellular Therapy · doi:10.1016/j.jtct.2023.01.009 · Cited by 27
Long-term outcome of reduced-intensity allogeneic hematopoietic SCT in patients with AML in CR
Popat, U., de Lima, M. J., Saliba, R. M., Anderlini, P. N., Andersson, B. S., Alousi, A. M., Hosing, C. M., Nieto, Y. L., Parmar, S., Khouri, I. F., et al. (2011) · Bone Marrow Transplantation · doi:10.1038/bmt.2011.61 · Cited by 27
Prognostic Risk Factor Evaluation in Patients With Relapsed or Refractory Multiple Myeloma Receiving Lenalidomide Treatment: Analysis of Renal Function by eGFR and of Additional Comorbidities by Comorbidity Appraisal
Kleber, M., Ihorst, G., Udi, J., Koch, B., Wäsch, R., & Engelhardt, M. M. (2011) · Clinical Lymphoma Myeloma & Leukemia · doi:10.1016/j.clml.2011.09.216 · Cited by 28
Treatment of Philadelphia chromosome‐positive acute lymphoblastic leukaemia with imatinib combined with a paediatric‐based protocol
Thyagu, S., Minden, M. D., Gupta, V. K., Yee, K. W. L., Schimmer, A. D., Schuh, A. C., Lipton, J. H., Messner, H. A., Xu, W., & Brandwein, J. M. (2012) · British Journal of Haematology · doi:10.1111/j.1365-2141.2012.09182.x · Cited by 27
Alternative novel therapies for the treatment of elderly acute myeloid leukemia patients
Isidori, A., Venditti, A., Maurillo, L., Buccisano, F., Loscocco, F., Manduzio, P., Sparaventi, G., Amadori, S., & Visani, G. (2013) · Expert Review of Hematology · doi:10.1586/17474086.2013.858018 · Cited by 27
Pulmonary function testing prior to reduced intensity conditioning allogeneic stem cell transplantation in an unselected patient cohort predicts posttransplantation pulmonary complications and outcome
Piñana, J. L., Martino, R., Barba, P., Bellido‐Casado, J., Valcárcel, D., Sureda, A. M., Briones, J., Brunet, S., Rodríguez-Arias, J. M., Casán, P., et al. (2011) · American Journal of Hematology · doi:10.1002/ajh.22183 · Cited by 27
A conditioning platform based on fludarabine, busulfan, and 2 days of rabbit antithymocyte globulin results in promising results in patients undergoing allogeneic transplantation from both matched and mismatched unrelated donor
Devillier, R., Fürst, S., Crocchiolo, R., Cheikh, J. E., Castagna, L., Harbi, S., Granata, A., D’Incan, E., Coso, D., Chabannon, C., et al. (2013) · American Journal of Hematology · doi:10.1002/ajh.23592 · Cited by 27
Predictive value of pretransplantation molecular minimal residual disease assessment by WT1 gene expression in FLT3-positive acute myeloid leukemia
Candoni, A., Marchi, F. D., Zanini, F., Zannier, M. E., Simeone, E., Toffoletti, E., Chiarvesio, A., Cerno, M., Fili, C. C., Patriarca, F. F., et al. (2017) · Experimental Hematology · doi:10.1016/j.exphem.2017.01.005 · Cited by 27
Iron overload in myelodysplastic syndromes: Evidence based guidelines from the Canadian consortium on MDS
Leitch, H. A., Buckstein, R. J., Zhu, N. Y., Nevill, T. J., Yee, K. W. L., Leber, B. F., Keating, M., St‐Hilaire, È., Kumar, R., Delage, R., et al. (2018) · Leukemia Research · doi:10.1016/j.leukres.2018.09.005 · Cited by 27
Cyclosporine A trough concentrations are associated with acute GvHD after non-myeloablative allogeneic hematopoietic cell transplantation
de Kort, E., de Lil, H. S., Bremmers, M. E. J., van Groningen, L. F. J., Blijlevens, N. M. A., Huls, G. A., Brüggemann, R. J. M., van Dorp, S., & van der Velden, W. J. F. M. (2019) · PLoS ONE · doi:10.1371/journal.pone.0213913 · Cited by 27
Who Is a Better Donor for Recipients of Allogeneic Hematopoietic Cell Transplantation: A Young HLA-Mismatched Haploidentical Relative or an Older Fully HLA-Matched Sibling or Unrelated Donor?
Karam, E., LaPorte, J., Solomon, S. R., Morris, L. E., Zhang, X., Holland, H. K., Bashey, A., & Solh, M. (2019) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2019.05.031 · Cited by 27
Machine Learning Algorithms to Differentiate Among Pulmonary Complications After Hematopoietic Cell Transplant
Sharifi, H., Lai, Y. K., Guo, H. H., Hoppenfeld, M. S., Guenther, Z. D., Johnston, L., Brondstetter, T. I., Chhatwani, L., Nicolls, M. R., & Hsu, J. L. (2020) · CHEST Journal · doi:10.1016/j.chest.2020.02.076 · Cited by 27
Venetoclax plus decitabine as a bridge to allogeneic haematopoietic stem-cell transplantation in older patients with acute myeloid leukaemia (VEN-DEC GITMO): final report of a multicentre, single-arm, phase 2 trial
Russo, D., Polverelli, N., Bernardi, S., Santarone, S., Farina, M., Borlenghi, E., Onida, F., Castagna, L., Bramanti, S., Carella, A. M., et al. (2024) · The Lancet Haematology · doi:10.1016/s2352-3026(24)00241-2 · Cited by 26
Umbilical Cord Blood Transplantation in Children with Acute Leukemia: Impact of Conditioning on Transplantation Outcomes
Eapen, M., Kurtzberg, J., Zhang, M., Hattersely, G., Fei, M., Mendizabal, A. M., Chan, K. W., Oliveira, S. N. D., Schultz, K. R., Wall, D. A., et al. (2017) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2017.06.023 · Cited by 26
Psychosocial Assessment of Candidates for Transplant (PACT) as a tool for psychological and social evaluation of allogeneic hematopoietic cell transplantation recipients
Hong, S., Rybicki, L. A., Corrigan, D., Dabney, J., Hamilton, B. K., Kalaycio, M. E., Lawrence, C., McLellan, L. J., Sobecks, R. M., Lee, S. J., et al. (2019) · Bone Marrow Transplantation · doi:10.1038/s41409-019-0455-y · Cited by 26
The NICE COVID‐19 rapid guideline on haematopoietic stem cell transplantation: development, implementation and impact
Orchard, K. H., Dignan, F. L., Lee, J., Pearce, R., Desai, M., McFarlane, E., Parkin, A., Shearn, P., & Snowden, J. A. (2021) · British Journal of Haematology · doi:10.1111/bjh.17280 · Cited by 26
Sleep Disruption, Fatigue, and Depression as Predictors of 6-Year Clinical Outcomes Following Allogeneic Hematopoietic Cell Transplantation
Rentscher, K. E., Carroll, J., Juckett, M., Coe, C. L., Broman, A. T., Rathouz, P. J., Hematti, P., & Costanzo, E. S. (2021) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djab032 · Cited by 30
Allogeneic stem cell transplantation as a curative option in relapse/refractory diffuse large B cell lymphoma: Spanish multicenter GETH/GELTAMO study
Bento, L., Gutierrez, A. M., Novelli, S., Montoro, J., Piñana, J. L., López‐Corral, L., Cabrero, M., Martı́n, A., Gutiérrez, G., Ortiz-Moscovich, M., et al. (2021) · Bone Marrow Transplantation · doi:10.1038/s41409-021-01264-3 · Cited by 26
Objective and subjective physical function in allogeneic hematopoietic stem cell transplant recipients
Mishra, A., Pidala, J., Thapa, R., Betts, B. C., Fernandez, H. F., Locke, F. L., Nishihori, T., Perez, L. E., Wang, X., Anasetti, C., et al. (2021) · Bone Marrow Transplantation · doi:10.1038/s41409-021-01428-1 · Cited by 26
Current Status and Perspectives of Allogeneic Hematopoietic Stem Cell Transplantation in Elderly Patients with Acute Myeloid Leukemia
Servais, S., Beguin, Y., & Baron, F. (2022) · Stem Cells Translational Medicine · doi:10.1093/stcltm/szac015 · Cited by 26
Self-citation
Bacterial Bloodstream Infections after Allogeneic Hematopoietic Stem Cell Transplantation: Etiology, Risk Factors and Outcome in a Single-Center Study
Gill, J., Busca, A., Cinatti, N., Passera, R., Dellacasa, C. M., Giaccone, L., Dogliotti, I., Manetta, S., Corcione, S., & Rosa, F. G. D. (2023) · Microorganisms · doi:10.3390/microorganisms11030742 · Cited by 26
Low‐ versus standard‐dose post‐transplant cyclophosphamide as GVHD prophylaxis for haploidentical transplantation
Fuji, S., Sugita, J., Najima, Y., Konishi, T., Tanaka, T., Ohigashi, H., Eto, T., Nagafuji, K., Hiramoto, N., Matsuoka, K., et al. (2023) · British Journal of Haematology · doi:10.1111/bjh.19228 · Cited by 26
The hematopoietic stem cell transplant comorbidity index can predict for 30-day readmission following autologous stem cell transplant for lymphoma and multiple myeloma
Jaglowski, S. M., Ruppert, A. S., Hofmeister, C. C., Elder, P., Blum, W. G., Klisovic, R. B., Vasu, S., Penza, S. L., Efebera, Y. A., Benson, D. M., et al. (2014) · Bone Marrow Transplantation · doi:10.1038/bmt.2014.155 · Cited by 26
Childhood Obesity and Outcomes after Bone Marrow Transplantation for Patients with Severe Aplastic Anemia
Barker, C. C., Agovi, A. M., Logan, B. R., Lazarus, H. M., Ballen, K. K., Gupta, V. K., Hale, G. A., Frangoul, H., Ho, V. T., Rizzo, J. D., et al. (2010) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2010.08.019 · Cited by 26

Authors: Sorror, M. L., Maris, M. B., Storb, R., Baron, F., Sandmaier, B. M., Maloney, D. G., & Storer, B.
Affiliations: University of Washington (US)
From the Fred Hutchinson Cancer Research Center, Seattle, WA; and the University of Washington, Seattle, WA.
ORCID: Sorror, Mohamed L.
Storb, Rainer
Sandmaier, Brenda M.
Maloney, David G.
Storer, Barry
Venue: Blood
Publisher: American Society of Hematology
Published: 2005-10-15
Volume: 106
Issue: 8
Pages: 2912-2919
ISSN: 0006-4971 (ISSN-L)
1528-0020
DOI: 10.1182/blood-2005-05-2004
PMC: PMC1895304
OpenAlex: W2128812336
Cited by: 2,969
References: 62
Citations by year: 2026: 139 · 2025: 208 · 2024: 223 · 2023: 213 · 2022: 192 · 2021: 246 · 2020: 209 · 2019: 171 · 2018: 173 · 2017: 174 · 2016: 144 · 2015: 145 · 2014: 134 · 2013: 112 · 2012: 86
FWCI: 25.46
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Blood (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
ORBi (University of Liège) (submittedVersion, other-oa)
Funders: Fred Hutchinson Cancer Research Center
University of Washington
National Heart, Lung, and Blood Institute (HL-36444, P01HL036444)
National Cancer Institute (CA 49605, CA18029, CA 15704+, K23CA092058, CA 78902, CA92058, P01CA049605, P30CA015704, P01CA018029, P01CA078902)
Topics: Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
Health Sciences › Medicine › Oncology › Inflammatory Biomarkers in Disease Prognosis
Health Sciences › Medicine › Transplantation › Renal Transplantation Outcomes and Treatments
Keywords: hematopoietic stem cell transplantation, allogeneic transplantation, comorbidity index, Charlson Comorbidity Index, risk assessment, non-relapse mortality, survival prediction, prognostic scoring
MeSH terms: Contraindications, Adolescent, Adult, Aged, Cause of Death, Child, Child, Preschool, Female, Humans, Infant, Male, Middle Aged, Prognosis, Transplantation, Homologous, Reproducibility of Results, Comorbidity, Survival Rate, Proportional Hazards Models, Treatment Outcome, Risk Assessment, Stem Cell Transplantation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks